AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 AUG 28 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced it was recently granted United States Patent No. 6,413,516 entitled "Peptides and Methods Against Psoriasis." The new patent includes composition and methods claims.
The vaccine may suppress the activity of specific T-cells that are thought to play a role in the development of psoriasis.
"This U.S. patent for our psoriasis TCR peptide vaccine strengthens our worldwide intellectual property position in therapeutic vaccines for autoimmune diseases," said Dr. Dennis J. Carlo, president and chief executive officer of the Immune Response Corp.
"With the addition of this psoriasis patent, we now have coverage in the major world markets for our TCR ...